00008-0100 Besponsa - CanMED: NDC

Product NDC:

00008-0100

Brand Name:

Besponsa

Generic Name:

Inotuzumab Ozogamicin

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: Inotuzumab Ozogamicin

Strength: 0.25

Unit: mg/mL

Packages:

Code: 00008-0100-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (0008-0100-01) / 4 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Aug. 18, 2017

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Drug Antibody Conjugate

Minor Class:

CD22

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox